Wu, C.-P.; Li, Y.-Q.; Chi, Y.-C.; Huang, Y.-H.; Hung, T.-H.; Wu, Y.-S.
The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. Int. J. Mol. Sci. 2021, 22, 9440.
https://doi.org/10.3390/ijms22179440
AMA Style
Wu C-P, Li Y-Q, Chi Y-C, Huang Y-H, Hung T-H, Wu Y-S.
The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. International Journal of Molecular Sciences. 2021; 22(17):9440.
https://doi.org/10.3390/ijms22179440
Chicago/Turabian Style
Wu, Chung-Pu, Yan-Qing Li, Ya-Chen Chi, Yang-Hui Huang, Tai-Ho Hung, and Yu-Shan Wu.
2021. "The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs" International Journal of Molecular Sciences 22, no. 17: 9440.
https://doi.org/10.3390/ijms22179440
APA Style
Wu, C. -P., Li, Y. -Q., Chi, Y. -C., Huang, Y. -H., Hung, T. -H., & Wu, Y. -S.
(2021). The Second-Generation PIM Kinase Inhibitor TP-3654 Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. International Journal of Molecular Sciences, 22(17), 9440.
https://doi.org/10.3390/ijms22179440